Myosin heavy chain 2A and α-Actin expression in human and murine skeletal muscles at feeding; particularly amino acids

  • Britt-Marie Iresjö1Email author and

    Affiliated with

    • Kent Lundholm1

      Affiliated with

      Journal of Translational Medicine201210:238

      DOI: 10.1186/1479-5876-10-238

      Received: 30 August 2012

      Accepted: 21 November 2012

      Published: 28 November 2012



      Protein dynamics during non-steady state conditions as feeding are complex. Such studies usually demand combinations of methods to give conclusive information, particularly on myofibrillar proteins with slow turnover. Therefore, time course transcript analyses were evaluated as possible means to monitor changes in myofibrillar biosynthesis in skeletal muscles in conditions with clinical nutrition; i.e. long term exposure of nutrients.


      Muscle tissue from overnight intravenously fed surgical patients were used as a model combined with muscle tissue from starved and refed mice as well as cultured L6 muscle cells. Transcripts of acta 1 (α-actin), mhc2A (myosin) and slc38 a2/Snat 2 (amino acid transporter) were quantified (qPCR) as markers of muscle protein dynamics.


      Myosin heavy chain 2A transcripts decreased significantly in skeletal muscle tissue from overnight parenterally fed patients but did not change significantly in orally refed mice. Alpha-actin transcripts did not change significantly in muscle cells from fed patients, mice or cultured L6 cells during provision of AA. The AA transporter Snat 2 decreased in L6 cells refed by all AA and by various combinations of AA but did not change during feeding in muscle tissue from patients or mice.


      Our results confirm that muscle cells are sensitive to alterations in extracellular concentrations of AA for induction of protein synthesis and anabolism. However, transcripts of myofibrillar proteins and amino acid transporters showed complex alterations in response to feeding with provision of amino acids. Therefore, muscle tissue transcript levels of actin and myosin do not reflect protein accretion in skeletal muscles at feeding.


      Myosin Actin Amino acids Skeletal muscles Snat2


      Several studies have reported on regulation of protein synthesis in skeletal muscles in fasted and fed state indicating considerably elevated synthesis during 2–3 hours postprandially [16]. Usually, such studies are based on estimates of protein synthesis by incorporation of labeled amino acids into newly synthesized proteins [710]; methods that are dependent on complex assumptions, related to distribution of tracers among intra- and extra cellular pools of amino acids [8, 11, 12], and represent expensive and complex analytical methods. [13, 14]. Consequently, alternative methods are needed in clinical studies. Therefore, tracer independent methods, measuring initiation of translational phosphoprotein complexes as well as cellular alterations in transcript concentrations of regulatory and target proteins for synthesis should be of value from several perspectives.

      Our previous studies have confirmed that extracellular provision of amino acids activates translation initiation of protein synthesis in skeletal muscle tissue during both oral and intravenous feeding [12, 15, 16]. Such induction of translation initiation may be triggered by concentration changes of amino acids outside or inside muscle cells through mTOR signaling without a critical presence of insulin or extracellular IGF-1 [1719]. However, strictly controlled experiments, based on labeled amino acids, did not provide consistent results on amino acid stimulation of total muscle protein synthesis, due to tissue pool- and tracee uncertainties [12, 20]. Therefore, the present study was conducted to evaluate how provision of extracellular amino acids influenced on cellular expressions and content of transcripts of amino acid transporters and myofibrillar MHC2A as well as α-actin as possible markers for the synthesis of contractile proteins in skeletal muscles at feeding relevant for clinical nutrition studies.

      Material and methods

      Patient studies

      Twelve patients who underwent upper gastrointestinal tract surgery participated [15]. They were randomized to receive overnight constant infusions of either saline or TPN, (Kabiven Perifer) for at least 12 hours prior to surgery as described elsewhere [15]. All infusions continued until muscle biopsies were taken from the rectus abdominis muscle directly after induction of anesthesia. Muscle biopsies with remaining intact RNA from 10 out of 12 randomized patients were used in present analyses. Amino acid concentrations in blood and translation initiation factor analyses from study and control patients have been reported elsewhere [15].

      Animal experiments

      Female, weight stable C57 BL/6 mice were used. They were either starved or refed with standard rodent chow (2016 Global Tekland®, Netherlands) and had always free access to water. Starved mice had no access to food overnight for 12 hours before termination, while refed animals were similarly starved overnight for 12 hours, but had then free access to food for 3 hours before termination [18]. Animals were killed by cervical dislocation and mixed hind limb muscles were excised and immediately frozen in liquid nitrogen. Muscle samples were stored at −70°C until RNA extractions were performed. All animal procedures were performed in accordance to national guidelines for animal research and approved by the regional animal research ethics committee in Gothenburg.

      Cell cultures

      Rat myoblast L6 cells were seeded in 25 cm2 flasks, 48 well- or 6-well dishes and grown to confluence in Dulbecco’s modified Eagle’s medium, with 4.5 g/l glucose (DMEM), supplemented with 10% foetal bovine serum (FBS), 100 IU/ml penicillin, 100 μg/ml streptomycin and 2 mM L-Glutamine. At day 4, when cells were confluent, medium was changed to standard DMEM supplemented with 2% FBS. At day 5, medium was changed to DMEM with very low amounts of all amino acids (0,14 mM), and without addition of FBS and antibiotics. Cells were cultured for 24 hours and thereafter cells were given new medium with either 0.28 mM amino acids (referred to as low AA) or 9 mM amino acids in total (referred to as high AA), which equals the concentration in standard DMEM. Cells were then cultured from 0.5-18 hours before harvest. In some experiments only groups of amino acids were included at elevated (high) concentrations in the medium while the remaining amino acids were kept at very low amino acid concentration (0.14 mM). Cells used in array experiments were harvested after 18 hours of refeeding. Cells were kept in an incubator with 95% air, 5% CO2 environment during the entire experiment.

      RNA isolation and cDNA synthesis

      RNA from L6 cells was extracted using RNeasy mini kit (Qiagen) with DNAse step included. Cells were lysed in RLT buffer according to kit instructions by adding lysis buffer directly to cells in the culture dishes. Cell lysates were collected and homogenized by flushing 10 times through a 20G needle. Skeletal muscle tissue was homogenized with an Ultra-Thurrax homogenizer and RNA from human and mouse muscle tissue was extracted by RNeasy fibrous tissue mini kit with DNAse step included. Total RNA concentrations were measured by spectrophotometer (Nanodrop ND-100) and RNA quality was checked using an Agilent 2100 bioanalyser and RNA 6000 Nano kit. One μg of total RNA was reverse transcribed to cDNA using oligo d(T)-primers according to kit instructions (Advantage® RT for PCR kit, Clontech). Positive and negative controls were included in each run of cDNA synthesis.

      Real-time PCR

      Commercially available primers from Qiagen were used for analysis of human α-actin/ ACTA 1 (QT00199815), rat α-actin/acta 1 (QT01081374), human myosin heavy chain 2A/MYH2 (QT00082495), human SLC38A2/(Snat 2) (QT 00030499), rat Slc38a2/(Snat 2) (QT00186116) and mouse Slc38a2/(Snat2) (QT00129542). Real time PCR was performed using QuantiTect™SYBR®Green PCR kit (Qiagen) according to kit instructions. 2 μl of cDNA and 2 μl of premixed Quantitect primers were used for each reaction of 20 μl exept for rat acta 1 where 5 μl cDNA were used. For analysis of mouse α-actin/acta 1 (5′-3′ Forward; CCAGAGTCAGAGCAGCAGA, Reverse CACGATGGATGGGAACAC), mouse myosin heavy chain 2A (5′-3′ Forward; TGGAGGGTGAGGTAGAGAGTG, Reverse; TTGGATAGATTTGTGTTGGATTG) primers were used. PCR analysis was performed with the PerfeCTa SYBR Green SuperMix (Quanta Biosciences) with the following settings; 95°-10 sek, 60°-30 sek, 72°-30 sek. 2 μl of cDNA and 3 pmol of each primer were used to a reaction of 10 μl. Real-time PCR was performed on either a LightCycler 1.5 instrument or a LightCycler 480 (Roche). Quantitative results were produced by the relative standard curve method and results are given in arbitrary units. All samples were analyzed in duplicates and negative controls were included in each run. Results from human and mice experiments are related to the expression of GAPDH as housekeeping gene which did not change significantly at starvation - refeeding. Results from cultured cells are reported as expression/ 18S. Levels of 18S RNA expression are provided separately since neither GAPDH nor 18S levels were stable at all experimental conditions in cell culture experiments. Only acta 1 (α-actin) and Slc38a2 (Snat 2) transcripts were measured in cell culture experiments since Mhc 2A transcripts were below detection levels when analyzed by real-time PCR.

      Microarray experiments

      Microarray analysis was performed on RNA from eight samples (4 starved, 4 refed). 500 ng of RNA from starved and refed cells (18 hour) were labeled with Cy-3-dCTP and Cy-5-dCTP respectively (Amersham BioSciences), in a cDNA synthesis reaction with Agilent Flourescent Direct Label. cDNA from starved versus refed cells were then hybridized in competition on Whole Rat Genome Microarrays (4x44K expression oligoarrays, Agilent) during 17 hrs followed by post-hybridization washes according to in situ instructions (Hybridization Kit Plus, Agilent). This provides relative changes in gene expression. Microarrays were quantified on Agilent G2565 AA microarray scanner and data were pre-processed in Feature Extraction software program (Agilent). Dye-normalized, outlier- and background subtracted values were imported into GeneSpring GX 10 software program (Agilent) for further analysis.

      Subcellular fractionation and labeling of cells

      Subcellular separation of the L6 cells was performed to check for protein expression of cytoskeletal proteins. L6 cells contained both actin as well as myosin heavy chains (Figure 1). Cells were labeled with 35S-Methionine as described elsewhere [12]. Both specific radioactivity and tracee concentrations of methionine were held constant in cell cultures when grown in presence of high or low amino acid concentrations. Stepwise subcellular fractionation of cells was performed by using Proteoextract® Subcellular proteome extraction kit (Calbiochem, Merck Biosciences) according to kit instructions. Cell fraction 4, which contains cytoskeletal proteins, was separated by electrophoresis and proteins were either stained by Coomassie brilliant blue or visualized by autoradiography as described elsewhere [12].
      Figure 1

      Electrophoretic separation of cytoskeletal proteins in L6 cells by stepwise purification . Cytoskeletal proteins were extracted using Calbiochems sub-cellular proteome extraction kit and separated by electrophoresis as described in Material and Methods. Lane 1–2 are autoradiograms of 35S-methionine labeled cells from low AA (lane 1) and high AA refed (lane 2) cells. Lane 3–4 are the same samples stained by Coomassie brilliant blue. Lane 5 is purified rabbit muscle actin (Sigma-Aldrich A-2522). Lane 6 is purified rabbit muscle myosin (Sigma-Aldrich M-1636). It has been demonstrated that L6 cells contain myosin [44].

      Incorporation of L-[U-14C]-phenylalanine (40 μCi/μmol phe) to cellular proteins was performed as described elsewhere in the presence of low or high medium concentrations of amino acids in the presence of constant concentration of phenylalanine (12μM).


      Results are presented as mean ±SE. Group comparisons were performed by factorial ANOVA followed by Fisher PLSD post hoc testing. p<0.05 was regarded statistically significant in two-tailed tests. Statistics used in the array experiment are described in the results section.


      Changes in transcript levels of myofibrillar proteins

      Skeletal muscle tissue from surgical patients, who received 12 hours continuous infusion of total parenteral nutrition, displayed significantly decreased MHC2A transcript levels compared to muscle tissue from control patients receiving saline only (p<0.05), while ACTA 1 transcripts were numerically decreased but did not reach statistical significance (Figure 2A). Similarly, both Mhc2A and acta 1 transcripts appeared to decline in skeletal muscles from refed mice compared to starved mice, but the difference did not reach statistical significance (Mhc2a p<0.18, Acta 1 p<0.10, n=16; Figure 2B). Similar findings occurred for Acta 1in confluent L6 cells refed low (0.28 mM) vs. high AA (9 mM) concentrations during 18 hours ( Acta 1, p<0.3, n=14; Figure 2C).
      Figure 2

      mRNA levels of Myosin heavy chain 2A, ACTA 1 and SLC38A2 in three different models with increased protein synthesis and translation initiation at amino acid provision . Rectus abdominus skeletal muscle tissue from surgical patients who received total parenteral nutrition compared to saline infusions for 12 hours; Mice “refed” with standard chow for 3 hours after 12 hours of starvation and L6 skeletal muscle cells cultured in presence of either low (0,28mM) or high (9 mM) total amino acid concentrations for 18 hours. Muscle MHC2A transcript levels were significantly decreased in parenterally fed patients (n=5) compared to saline infused control patients (n=5) (* p<0.05) while Mhc 2A /acta 1 transcrips were not different in mixed hind limb muscle tissue from starved/refed mice (Acta 1 p<0.10, MCH2A p<0.18, n=16) or cultured L6 cells (p<0.3). Slc38a2 (Snat2) levels were significantly decreased in L6 cells cultured in presence of high amino acid concentrations (p<0.01).

      Acta 1 transcripts increased significantly at 60 min of AA refeeding compared to 24 hours starved cells (cultured in presence of very low AA concentrations (0.14 mM) for 24 hours, before start of refeeding) with no difference between low and high AA groups (Figure 3A; n=9). Acta 1 levels remained increased at 4 and 8 hours compared to 24 hours starved cells, without any differences between low and high AA groups (4 hours; Low AA 0.818±0.273, High AA 1.141±0.796 , 8 hours; Low AA 1.152±0.740, High AA 0,992±0,330; n=3). Refed confluent L6 cells, based on different groups of AA at high concentrations for 18 hours, did not result in clear-cut significant alterations of Acta 1 levels among the groups (Figure 4A).
      Figure 3

      mRNA levels of acta 1 and slc38a2 in confluent L6 cells refed low (0.28 mM) or high (9 mM) total amino amino acid concentrations compared to cells cultured for 24 hours in starvation medium (0,14 mM) as described in Materials and methods . Acta 1 was significantly increased in low and high AA refed cells at 60 min compared to 24 hours starved cells (p<0.01). Slc38a2 concentrations were decreased at 60 min (p<0.05, n=9).
      Figure 4

      Transcript levels of acta 1and slc38a2 (Snat 2) in confluent L6 cells refed various groups of amino acids . L6 cells were cultured in the presence of low AA (0.28 mM) or high AA (9 mM) concentrations of all amino acids, or in the presence of high concentrations of various groups of amino acids (BCAA, aromatics, gln) in addition to background concentration of all amino acids in DMEM (0.14 mM) as described in Material and Methods. All cells were cultured in medium with decreased amounts of all amino acids (0.14 mM) for an initial period of 24 hours. Media were changed and cells were cultured in the presence of either low AA (0.28 mM), high AA (9 mM) or group amino acids for further 18 hours. (* p< 0.05 vs. refed low). RFBCAA = refed by BCAA (2.5 mM), RFArom = refed by aromatic amino acids (1mM), RFGlu = refed by Gln, Lys, Arg, Thr, His (5.3 mM).

      Changes in transcript levels of amino acid transporter slc38a2/Snat 2

      SLC38A2 (Snat2) levels did not differ between skeletal muscles from TPN and saline infused patients (P<0,7) as well as in refed mice compared to starved mice (Figure 2A,B). In contrast, Slc38a2 (Snat2) levels were significantly lower in L6 cells refed high AA concentrations during 18 hours compared to cells receiving low amino acid concentrations. (p<0,001) (Figure 2C). The discrepancies between slc38a2 transcripts at 60 min (Figure 3B) and 18 hours (Figure 4B) appeared to emerge beyond 4 hours incubation at high versus low AA concentrations (4 hours; Low AA 14.7±3.2, High AA 10.4±2.5, 8hours; Low AA 19,6±5.1, High AA 5.0±1.3; n=3) Based on these findings we chose 18 hours incubation for comparisons among groups of AA experiments. Cellular Slc38a2 (Snat2) transcripts were thus influenced by refeeding by various combinations of amino acids for 18 hours. Cells refed by branched chain amino acids (leu, ile, val) or by glutamine in the presence of other non-essential amino acids (Arg, Thr, His, Lys) showed decreased levels of Slc38a2 (Snat2) transcripts, while refeeding by aromatics (phe, tyr, trp) or sulphur amino acids (met, cys) in the presence of all amino acids in DMEM at low background concentration (0.14 mM) did not alter Slc38a2 mRNA levels (Figure 4 B).

      Total protein synthesis in cultured L6 cells

      Incorporation of 14C-phenylalanine into total cellular proteins increased continuously in the presence of amino acids and was significantly higher in the presence of high amino acids in the medium after 20 hours incubation compared to cells incubated with low amino acid concentrations (Figure 5).
      Figure 5

      Time course changes in L-[U- 14 C]-phenylalanine incorporation into proteins. Confluent L6 cells were cultured in medium containing very low amounts of amino acids (0,14 mM) for 24 hours, and then refed in low (0,28 mM) or high (9 mM) concentration of total AA concentrations, with constant specific radioactivity of phenylalanine (40 μCi/μmol phe). Cells were harvested by TCA-precipitation of proteins. (* p< 0.01 vs. low AA).

      Microarray results

      Of 41 090 probes on the Agilent 4 × 44K whole genome rat array, 22 318 entities remained after filtering of flags to remove low expressed genes. Statistical evaluation by t-test with Benjamini-Hochberg correction for multiple significance showed that 6675 entities were significantly different between starved and refed cells (p< 0.05). 745 entities showed at least 2 fold changes and were used for further analysis (399 up-, 346 down-regulated). A search by name (actin, myosin, tropo and slc) among the significantly changed transcripts with a fold change above 2 was performed in order to find mRNAs for amino acid transporters and contractile proteins. Several amino acid transporters demonstrated alterations in expression levels in response to provision of amino acids to cell cultures (Table 1). A gene ontology (GO) analysis was performed to find categories/pathways with significant enrichment of genes. Ten GO categories were found; all related to lipid, cholesterol and steroid metabolism (Table 2). Differentially expressed entities in GO cathegories “steroid biosynthethic and metabolic processes” are presented in Table 3. These results provide evidence that amino acid have profound effects on intermediary and nitrogen metabolism in muscle cells.
      Table 1

      Altered transcript levels of amino acid transporters and muscle proteins in confluent L6 muscle cells refed high amino acid concentrations versus low amino acid concentration assessed in microarray experiments as described in Material and Methods

      Agilent entity

      Foldchange array

      Foldchange Q-PCR

      Common name

      Gene symbol

      Protein name/Function






      Snat 2/ System A transporter






      Glyt1/ System Gly transporter






      Snat 2/ System A transport






      Taut/ System BETA, taurine transport






      Lat 3/ System L-like transporter






      Troponin T2, cardiac






      Myosin 1D






      Myosin heavy chain, smooth muscle isoform

      Table 2

      GO categories with significant enrichment of entities in L6 cells refed high amino acid concentrations

      GO ID

      GO Accession nr

      GO Term

      Corrected p-value



      sterol biosynthetic process

      1.289 E-12



      cholesterol biosynthetic process

      3.812 E-9



      steroid biosynthetic process

      9.406 E-8



      sterol metabolic process

      9.406 E-8



      lipid biosynthetic process

      7.391 E-7



      lipid metabolic process

      4.741 E-6



      cellular lipid metabolic process

      3.867 E-6



      alcohol metabolic process

      2.552 E-6



      cholesterol metabolic process

      2.552 E-6



      steroid metabolic process

      1.768 E-4

      Based on entities selected by fold change ≥2.

      Table 3

      Altered transcript levels (entities) in GO categories “steroid biosynthetic and metabolic processes” in confluent L6 muscle cells refed high amino acid concentrations

      Agilent entity

      Foldchange array

      Foldchange Q-PCR

      Common name








      Squalene epoxidase






      Transmembrane 7 superfamily member 2






      Acetyl-Coenzyme A acetyltransferase 2






      Mevalonate (diphospho) decarboxylase






      Isopentenyl-diphosphate delta isomerase






      Isopentenyl-diphosphate delta isomerase ]






      7-dehydrocholesterol reductase






      3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1






      Cytochrome P450, subfamily 51






      3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1






      Scavenger receptor class B, member 1






      Hydroxysteroid (17-beta) dehydrogenase 7






      Lanosterol synthase (Lss)






      Scavenger receptor class B, member 1






      Farensyl diphosphate synthase (Fdps)






      NAD(P) dependent steroid dehydrogenase-like






      24-dehydrocholesterol reductase






      Phenylalkylamine Ca2+ antagonist (emopamil) binding protein






      Farensyl diphosphate synthase






      3-hydroxy-3-methylglutaryl-Coenzyme A reductase






      Sterol-C4-methyl oxidase-like






      3-hydroxy-3-methylglutaryl-Coenzyme A reductase






      ATP-binding cassette, sub-family G (WHITE), member 1






      Cholesterol 25-hydroxylase


      A large number of studies have evaluated rates and translation initiation of total protein synthesis in skeletal muscles in response to feeding during recent decades [13, 21]. However, such studies, mainly based on incorporation of labeled amino acids, suffer from uncertainties and complex assumptions for calculation of protein synthesis rate [10, 11, 2224]. Difficulties occur particularly at rapid alterations in bio-dynamics during non-steady state conditions [10, 14]. Therefore, alternative and tracer independent methods have recently been applied in both animal and clinical experiments, complementary to tracer based methods. Such techniques are mainly based on assessment of phosphorylation/de-phosphorylation of regulatory proteins or protein complexes related to translation initiation of proteins where advantages are straight forward assessment of protein phosphorylation status in cells and tissues under evaluation without the need of steady state [6, 15]. Tissue sampling and processing are comparatively easy and analytical principles are robust at standardized conditions [15]. However, limitations are that results reflect only initiation of overall protein bio-synthesis and do not reflect alterations of defined proteins. Determinations of the amount of a particular protein(s) in skeletal muscle tissue should in part resolve this problem, but is only applicable in long-term experiments, since it would be practically difficult to correctly assess quantitative alterations of defined proteins in skeletal muscle cells during short-term responses. Therefore, it should be possible to obtain relevant information by assessment of tissue transcript levels of defined myofibrillar proteins in response to feeding as applied in studies on orally refed healthy volunteers [25]. Unexpectedly, it was then observed that oral refeeding caused a decline of myofibrillar transcripts in skeletal muscles, at conditions otherwise associated with anabolic metabolism [16, 2628]. Such transcript information was seen in the light of observations that stimulation of gene transcription is usually reflected by increased tissue levels of transcripts for defined proteins aimed at subsequent translation to meet cellular requirements. [2932]. Therefore, expected findings should be that net efflux of amino acids from skeletal muscles, due to increased net protein breakdown, should be associated with postprandial down-regulation in transcription of myofibrillar proteins. Normal oral feeding which is leading to rapid and pronounced activation of skeletal muscle protein synthesis, should then be characterized by increased transcription of required proteins [33]. Based on this simplistic view, we decided to re-evaluate effects on transcripts of myofibrillar proteins as Myosin heavy chain 2A (myosin) and acta 1 (α-actin) in skeletal muscle tissue in response to refeeding, particularly with focus on effects by amino acids in both patient and animal experiments.

      Myosin heavy chains contributes to 20-25% of overall muscle protein synthesis in humans [34, 35] while actin may display both lower and higher turnover compared to mixed muscle proteins [35, 36]. Muscle tissue is however composed of many different proteins where sarcoplasmatic and myofibrillar proteins have different basal turnover and synthesis rates at feeding [37]. Adult human muscle tissue expresses three different isoforms of myosin heavy chain (MHC-I, MHC-IIa and MHC-IIx), where MHC-IIa is highly expressed in humans, while rodents express one additional form (MHC-IIb) [38].The myosin gene family is located in a cluster on chromosome 17 in humans and on chromosome 11 in mice [39]. Studies have indicated that mRNA content of different myosin isoforms correlates to the relative content of various MHC proteins present in skeletal muscle tissue [40, 41] Changes in expression patterns of myosin heavy chain proteins exist in skeletal muscles during hypertrophy in the control of net muscle mass subsequent to loading [4246], but less is known in response to feeding, although Mhc 2X mRNA is reported to unexpectedly increase after 7 days at reduced oral intake in rats [47]. Our present findings show that that transcripts of myosin heavy chain 2A and actin appeared to decrease during continuous TPN administration in agreement with previous findings showing decreased MHC 2X mRNA levels at 3 hours after oral meal intake [25];conditions that provide increased formation of eIF4G·eIF4E complex and decreased association of 4E-BP1·eIF4E [15].

      There may be several reasons why myosin transcripts do not clear-cut reflect transcriptional activities and translational needs in cells during continuous long term nutrition exposure, although Rennie and coworkers [48] have reported transient changes in myofibrillar protein synthesis suggesting that muscle cells become refractory to amino acids in response to oral bolus feeding. However, long term provision of intravenous nutrition to patients leads to both time-proportional increases in muscle mass and continuously increased incorporation of labeled amino acids during the presence of high amino acid provision as seen in our present cell experiment (Figure 5). Therefore, it appears that transcript cellular levels of actin and myosin are influenced by a variety of factors that possibly determine absolute levels in both short and long term perspectives at nutrition.

      It has never been finally assessed how amino acids signal across cell membranes to elicit triggers for induction of translation initiation, although it is assumed there are extracellular/intracellular amino acid sensors since muscle cells are sensitive to alterations of amino acid concentrations [49]. Recently, amino acid transporter proteins gained increased interest based on their ability to sense amino acid changes and influence intracellular signaling [50]. Regulation of expression of amino acid transporters may thus be an important part of the cell machinery in control of protein synthesis secondary to amino acids availability [49, 51]. Therefore, we investigated how transcription of the transporter protein Snat 2 (encoded by the gene slc38a2) was affected by refeeding in our models. Snat 2 is a transporter of neutral amino acids belonging to system A [52]. Several amino acids in the refeeding medium (glutamine, histidine, cysteine, methonine) are transported by Snat 2, while branched chain- and aromatics are transported by system L across cell membranes [51, 52]. Amino acid transporting by system A increased following amino acid deprivation [53]. Accordingly, we found that Snat 2 mRNA was lower in refed L6 cells compared to starved cells, although such alterations were not evident in vivo. Concentrations of Snat 2 mRNA were also decreased in refed cells by a group of amino acids (Gln, His, Lys, Arg, Thr). Refeeding L6 cells by branched chain amino acids decreased Snat 2 mRNA, although transported by system L, which operates by 1:1 amino acid exchange, which may couple influx of branched chain amino acids to efflux of cytoplasmatic amino acids such as glutamine [54]. It is possible that refeeding cells with branched chain amino acids caused either efflux or influx of other amino acids, which may alter Snat 2 mRNA levels. If so, Snat 2 should be influenced by extra cellular concentrations or transmembrane fluxes of either Gln or His, since it was not changed by refeeding of cysteine or methione which are Snat 2 substrates.

      Our microarray data on cultured cells confirm that amino acids have pronounced effects on steroid and lipid metabolism in skeletal muscle cells. Only GO categories/pathways related to lipid and steroid metabolism showed significant enrichment, although microarray experiments indicated that a large number of individual transcripts (30%) were changed following amino acid provision. It has been reported earlier that skeletal muscle cells are capable of local synthesis of sex steroid hormones [55], and there are several ways for cells to provide cholesterol for use in steroid synthesis, such as the mevalonate pathway, where cholesterol is synthesized through a series of enzyme reactions from Acetyl CoA and HMG-CoA [56, 57]. Thus, it was interesting to find that transcripts of all enzymes in this pathway were increased following amino acid provision to L6 cells. The expression of steroids and enzymes increases after exercise and may therefore represent an important part of anabolism following physical training in skeletal muscles [58]. Thus, results in the present study confirm that amino acids have profound metabolic effects upstream to initiation of protein synthesis in cultured isolated skeletal muscle cells, as observed in animal and human skeletal muscle tissue [12, 5964], in part related to individual groups of amino acids [6569], as also observed in human biopsy specimens [17, 61].


      In conclusion, previous and present studies confirm that skeletal muscle cells are sensitive to alterations in extracellular concentrations of amino acids for translation initiation of protein synthesis, usually indicated by polysome aggregation, increased incorporation of amino acids into cellular proteins and activation of translation initiation [12, 15, 19]. However, transcripts of myofibrillar proteins and amino acid transporters showed unexpected complex time course changes in response to various conditions of refeeding and should therefore be used only in combination with other indicators of muscle protein synthesis. Thus, tissue levels of actin and myosin transcripts are not suitable as in vivo markers for protein accretion in skeletal muscles in response to feeding.



      We would like to thank Ph.D. Christina Lönnroth and Marianne Andersson for advice and technical help in performing the microarray analyses.

      Supported in parts by grants from the Swedish Cancer Society (2014), the Swedish Research Council (08712), Assar Gabrielsson Foundation (AB Volvo), Jubileumskliniken Foundation, IngaBritt & Arne Lundberg Research Foundation, Swedish and Gothenburg Medical Societies and the Medical Faculty, University of Gothenburg, Sahlgrenska University Hospital Foundation, Swedish Nutrition Foundation.

      Authors’ Affiliations

      Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital


      1. Waterlow JC, Garlick P, Millward DJ: Protein turnover in mammalian tissues and in the whole body. Amsterdam: Elsevier/North-Holland Biomedical Press; 1978.
      2. Garlick PJ, Clugston GA, McNurlan MA, Preedy VR, Fern EB: Nutrition and protein turnover. Biochem Soc Trans 1982, 10:290–291.PubMed
      3. Garlick PJ, McNurlan MA, Ballmer PE: Influence of dietary protein intake on whole-body protein turnover in humans. Diabetes Care 1991, 14:1189–1198.PubMedView Article
      4. McNurlan MA, Garlick PJ: Influence of nutrient intake on protein turnover. Diabetes Metab Rev 1989, 5:165–189.PubMedView Article
      5. Millward DJ, Nnanyelugo DO, James WP, Garlick PJ: Protein metabolism in skeletal muscle: the effect of feeding and fasting on muscle RNA, free amino acids and plasma insulin concentrations. Br J Nutr 1974, 32:127–142.PubMedView Article
      6. Avruch J, Long X, Ortiz-Vega S, Rapley J, Papageorgiou A, Dai N: Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab 2009, 296:E592-E602.PubMedView Article
      7. James WP, Garlick PJ, Sender PM, Waterlow JC: Studies of amino acid and protein metabolism in normal man with L-[U- 14C]tyrosine. Clin Sci Mol Med 1976, 50:525–532.PubMed
      8. Ballmer PE, McNurlan MA, Milne E, Heys SD, Buchan V, Calder AG, Garlick PJ: Measurement of albumin synthesis in humans: a new approach employing stable isotopes. Am J Physiol 1990, 259:E797-E803.PubMed
      9. Calder AG, Anderson SE, Grant I, McNurlan MA, Garlick PJ: The determination of low d5-phenylalanine enrichment (0.002–0.09 atom percent excess), after conversion to phenylethylamine, in relation to protein turnover studies by gas chromatography/electron ionization mass spectrometry. Rapid Commun Mass Spectrom 1992, 6:421–424.PubMedView Article
      10. Wagenmakers AJ: Tracers to investigate protein and amino acid metabolism in human subjects. Proc Nutr Soc 1999, 58:987–1000.PubMedView Article
      11. Fern EB, Garlick PJ: The specific radioactivity of the tissue free amino acid pool as a basis for measuring the rate of protein synthesis in the rat in vivo. Biochem J 1974, 142:413–419.PubMed
      12. Iresjo BM, Svanberg E, Lundholm K: Reevaluation of amino acid stimulation of protein synthesis in murine- and human-derived skeletal muscle cells assessed by independent techniques. Am J Physiol Endocrinol Metab 2005, 288:E1028-E1037.PubMedView Article
      13. El-Haroun ER, Bureau DP, Cant JP: A mechanistic model of nutritional control of protein synthesis in animal tissues. J Theor Biol 2010, 262:361–369.PubMedView Article
      14. Wolfe RR, Song J, Sun J, Zhang XJ: Total aminoacyl-transfer RNA pool is greater in liver than muscle in rabbits. J Nutr 2007, 137:2333–2338.PubMed
      15. Iresjo BM, Körner U, Hyltander A, Ljungman D, Lundholm K: Initiation factor for translation of proteins in the rectus abdominis muscle from patients on overnight standard parenteral nutrition before surgery. Clin Sci 2008, 114:603–610.PubMedView Article
      16. Lundholm K, Bennegard K, Zachrisson H, Lundgren F, Eden E, Moller-Loswick AC: Transport kinetics of amino acids across the resting human leg. J Clin Invest 1987, 80:763–771.PubMedView Article
      17. Lundholm K, Schersten T: Protein synthesis in human skeletal muscle tissue: influence of insulin and amino acids. Eur J Clin Invest 1977, 7:531–536.PubMedView Article
      18. Svanberg E, Jefferson LS, Lundholm K, Kimball SR: Postprandial stimulation of muscle protein synthesis is independent of changes in insulin. Am J Physiol 1997, 272:E841-E847.PubMed
      19. Svanberg E, Zachrisson H, Ohlsson C, Iresjo BM, Lundholm KG: Role of insulin and IGF-I in activation of muscle protein synthesis after oral feeding. Am J Physiol 1996, 270:E614-E620.PubMed
      20. Svanberg E, Moller-Loswick AC, Matthews DE, Korner U, Andersson M, Lundholm K: Effects of amino acids on synthesis and degradation of skeletal muscle proteins in humans. Am J Physiol 1996, 271:E718-E724.PubMed
      21. Arnal M, Obled C, Attaix D, Patureau-Mirand P, Bonin D: Dietary control of protein turnover. Diabete Metab 1987, 13:630–642.PubMed
      22. Davis TA, Reeds PJ: Of flux and flooding: the advantages and problems of different isotopic methods for quantifying protein turnover in vivo: II, Methods based on the incorporation of a tracer. Curr Opin Clin Nutr Metab Care 2001, 4:51–56.PubMedView Article
      23. Li JB, Fulks RM, Goldberg AL: Evidence that the intracellular pool of tyrosine serves as precursor for protein synthesis in muscle. J Biol Chem 1973, 248:7272–7275.PubMed
      24. Garlick PJ: An analysis of errors in estimation of the rate of protein synthesis by constant infusion of a labelled amino acid. Biochem J 1978, 176:402–405.PubMed
      25. Svanberg E, Ennion S, Isgaard J, Goldspink G: Postprandial resynthesis of myofibrillar proteins is translationally rather than transcriptionally regulated in human skeletal muscle. Nutrition 2000, 16:42–46.PubMedView Article
      26. Hyltander A, Warnold I, Eden E, Lundholm K: Effect on whole-body protein synthesis after institution of intravenous nutrition in cancer and non-cancer patients who lose weight. Eur J Cancer 1991, 27:16–21.PubMedView Article
      27. Moller-Loswick AC, Bennegard K, Lundholm K: The forearm and leg perfusion techniques in man do not give the same metabolic information. Clin Physiol 1991, 11:385–395.PubMedView Article
      28. Bennegard K, Eden E, Ekman L, Schersten T, Lundholm K: Metabolic response of whole body and peripheral tissues to enteral nutrition in weight-losing cancer and noncancer patients. Gastroenterology 1983, 85:92–99.PubMed
      29. Essen P, McNurlan MA, Wernerman J, Milne E, Vinnars E, Garlick PJ: Short-term starvation decreases skeletal muscle protein synthesis rate in man. Clin Physiol 1992, 12:287–299.PubMedView Article
      30. Baillie AG, Garlick PJ: Responses of protein synthesis in different skeletal muscles to fasting and insulin in rats. Am J Physiol 1991, 260:E891-E896.PubMed
      31. Millward DJ, Garlick PJ, Nnanyelugo DO, Waterlow JC: The relative importance of muscle protein synthesis and breakdown in the regulation of muscle mass. Biochem J 1976, 156:185–188.PubMed
      32. Tjader I, Essen P, Thorne A, Garlick PJ, Wernerman J, McNurlan MA: Muscle protein synthesis rate decreases 24 hours after abdominal surgery irrespective of total parenteral nutrition. JPEN J Parenter Enteral Nutr 1996, 20:135–138.PubMedView Article
      33. Tawa NE Jr, Goldberg AL: Suppression of muscle protein turnover and amino acid degradation by dietary protein deficiency. Am J Physiol 1992, 263:E317-E325.PubMed
      34. Balagopal P, Ljungqvist O, Nair KS: Skeletal muscle myosin heavy-chain synthesis rate in healthy humans. Am J Physiol 1997, 272:E45-E50.PubMed
      35. Hasten DL, Morris GS, Ramanadham S, Yarasheski KE: Isolation of human skeletal muscle myosin heavy chain and actin for measurement of fractional synthesis rates. Am J Physiol 1998, 275:E1092-E1099.PubMed
      36. Bates PC, Grimble GK, Sparrow MP, Millward DJ: Myofibrillar protein turnover. Synthesis of protein-bound 3-methylhistidine, actin, myosin heavy chain and aldolase in rat skeletal muscle in the fed and starved states. Biochem J 1983, 214:593–605.PubMed
      37. Bates PC, Millward DJ: Myofibrillar protein turnover, Synthesis rates of myofibrillar and sarcoplasmic protein fractions in different muscles and the changes observed during postnatal development and in response to feeding and starvation. Biochem J 1983, 214:587–592.PubMed
      38. Harridge SD: Plasticity of human skeletal muscle: gene expression to in vivo function. Exp Physiol 2007, 92:783–797.PubMedView Article
      39. Weiss A, Leinwand LA: The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol 1996, 12:417–439.PubMedView Article
      40. Gunawan AM, Park SK, Pleitner JM, Feliciano L, Grant AL, Gerrard DE: Contractile protein content reflects myosin heavy-chain isoform gene expression. J Anim Sci 2007, 85:1247–1256.PubMedView Article
      41. Toth MJ, Tchernof A: Effect of age on skeletal muscle myofibrillar mRNA abundance: relationship to myosin heavy chain protein synthesis rate. Exp Gerontol 2006, 41:1195–1200.PubMedView Article
      42. Glass DJ: Molecular mechanisms modulating muscle mass. Trends Mol Med 2003, 9:344–350.PubMedView Article
      43. Glass DJ: Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005, 37:1974–1984.PubMedView Article
      44. Sundaram P, Pang Z, Miao M, Yu L, Wing SS: USP19-deubiquitinating enzyme regulates levels of major myofibrillar proteins in L6 muscle cells. Am J Physiol Endocrinol Metab 2009, 297:E1283-E1290.PubMedView Article
      45. Giger JM, Bodell PW, Zeng M, Baldwin KM, Haddad F: Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin. J Appl Physiol 2009, 107:1204–1212.PubMedView Article
      46. Haddad F, Roy RR, Zhong H, Edgerton VR, Baldwin KM: Atrophy responses to muscle inactivity. I. Cellular markers of protein deficits. J Appl Physiol 2003, 95:781–790.PubMed
      47. Svanberg E, Kiri A, Isgaard J, Goldspink G: Semi-starvation alters myofibrillar mRNA concentrations to expedite rapid recovery of muscle protein stores following feeding. Eur J Clin Invest 2000, 30:722–728.PubMedView Article
      48. Atherton PJ, Etheridge T, Watt PW, Wilkinson D, Selby A, Rankin D, Smith K, Rennie MJ: Muscle full effect after oral protein: time-dependent concordance and discordance between human muscle protein synthesis and mTORC1 signaling. Am J Clin Nutr 2010, 92:1080–1088.PubMedView Article
      49. Hundal HS, Taylor PM: Amino acid transceptors: gate keepers of nutrient exchange and regulators of nutrient signaling. Am J Physiol Endocrinol Metab 2009, 296:E603-E613.PubMedView Article
      50. Drummond MJ, Glynn EL, Fry CS, Timmerman KL, Volpi E, Rasmussen BB: An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. Am J Physiol Endocrinol Metab 2010, 298:E1011-E1018.PubMedView Article
      51. Waterlow JC, Garlick P, Millward DI: Free amino acids. In Protein turnover in mammalian tissues and in the whole body. Amsterdam: Elsevier/North-Holland Biomedical Press; 1978:117–176.
      52. Hyde R, Taylor PM, Hundal HS: Amino acid transporters: roles in amino acid sensing and signalling in animal cells. Biochem J 2003, 373:1–18.PubMedView Article
      53. Kashiwagi H, Yamazaki K, Takekuma Y, Ganapathy V, Sugawara M: Regulatory mechanisms of SNAT2, an amino acid transporter, in L6 rat skeletal muscle cells by insulin, osmotic shock and amino acid deprivation. Amino Acids 2009, 36:219–230.PubMedView Article
      54. Evans K, Nasim Z, Brown J, Butler H, Kauser S, Varoqui H, Erickson JD, Herbert TP, Bevington A: Acidosis-sensing glutamine pump SNAT2 determines amino acid levels and mammalian target of rapamycin signalling to protein synthesis in L6 muscle cells. J Am Soc Nephrol 2007, 18:1426–1436.PubMedView Article
      55. Aizawa K, Iemitsu M, Maeda S, Jesmin S, Otsuki T, Mowa CN, Miyauchi T, Mesaki N: Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats. Am J Physiol Endocrinol Metab 2007, 292:E577-E584.PubMedView Article
      56. Payne AH, Hales DB: Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004, 25:947–970.PubMedView Article
      57. Hu J, Zhang Z, Shen WJ, Azhar S: Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab (Lond) 2010, 7:47.View Article
      58. Aizawa K, Iemitsu M, Otsuki T, Maeda S, Miyauchi T, Mesaki N: Sex differences in steroidogenesis in skeletal muscle following a single bout of exercise in rats. J Appl Physiol 2008, 104:67–74.PubMedView Article
      59. Garlick PJ, Preedy VR, Reeds PJ: Regulation of protein turnover in vivo by insulin and amino acids. Prog Clin Biol Res 1985, 180:555–564.PubMed
      60. Garlick PJ, Millward DJ, James WP: The diurnal response of muscle and liver protein synthesis in vivo in meal-fed rats. Biochem J 1973, 136:935–945.PubMed
      61. Lundholm K, Edstrom S, Ekman L, Karlberg I, Walker P, Schersten T: Protein degradation in human skeletal muscle tissue: the effect of insulin, leucine, amino acids and ions. Clin Sci 1981, 60:319–326.PubMed
      62. Garlick PJ, Grant I: Amino acid infusion increases the sensitivity of muscle protein synthesis in vivo to insulin, Effect of branched-chain amino acids. Biochem J 1988, 254:579–584.PubMed
      63. Adibi SA: Metabolism of branched-chain amino acids in altered nutrition. Metabolism 1976, 25:1287–1302.PubMedView Article
      64. Holecek M: Relation between glutamine, branched-chain amino acids, and protein metabolism. Nutrition 2002, 18:130–133.PubMedView Article
      65. McNurlan MA, Fern EB, Garlick PJ: Failure of leucine to stimulate protein synthesis in vivo. Biochem J 1982, 204:831–838.PubMed
      66. Fulks RM, Li JB, Goldberg AL: Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem 1975, 250:290–298.PubMed
      67. May ME, Buse MG: Effects of branched-chain amino acids on protein turnover. Diabetes Metab Rev 1989, 5:227–245.PubMedView Article
      68. Buse MG, Reid SS: Leucine, A possible regulator of protein turnover in muscle. J Clin Invest 1975, 56:1250–1261.PubMedView Article
      69. Matthews DE: Observations of branched-chain amino acid administration in humans. J Nutr 2005, 135:1580S-1584S.PubMed


      © Iresjo and Lundholm; licensee BioMed Central Ltd. 2012

      This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.